Patent details

Basic Information

Publication number:

EP3444261

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP171758857

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2,2-DIFLUOROPROPIONAMIDE DERIVATIVE OF BARDOXOLONE METHYL, PHARMACEUTICAL COMPOSITIONS AND POLYMORPHS THEREOF FOR USE IN TREATING CERTAIN CONDITIONS

French Title of Invention:

DÉRIVÉ 2,2-DIFLUOROPROPIONAMIDE DE MÉTHYLE DE BARDOXOLONE, COMPOSITIONS PHARMACEUTIQUES LE CONTENANTS ET SES FORMES POLYMORPHES POUR LE TRAITEMENT DE CERTAINES MALADIES

German Title of Invention:

2,2-DIFLUORPROPIONAMID-DERIVAT VON BARDOXOLONMETHYL, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND POLYMORPHE DAVON ZUR BEHANDLUNG VON KRANKHEITEN

SPC Number:

Dates

Filing date:

24/04/2013

Grant date:

13/01/2021

EP Publication Date:

20/02/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/01/2021

EP B1 Publication Date:

13/01/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/04/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/04/2023

 

 

Name:

REATA PHARMACEUTICALS HOLDINGS, LLC

Address:

5320 Legacy Drive, Plano, 75024, Texas, Texas, United States (US)

History of Owners

From:

06/01/2021

To:

27/04/2023

Name:

Reata Pharmaceuticals, Inc.

Address:

2801 Gateway Drive, Suite 150, Irving, TX 75063-2648, United States (US)

Agent

Name:

NOVAGRAAF BREVETS

From:

17/03/2021

Address:

BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)

To:

Inventor

1

Name:

LIU, Xiaofeng

Address:

United States (US)

2

Name:

ANDERSON, Eric

Address:

United States (US)

3

Name:

DECKER, Andrea

Address:

Switzerland (CH)

Priority

1

Priority Number:

201261687669 P

Priority Date:

27/04/2012

Priority Country:

United States (US)

2

Priority Number:

201361775288 P

Priority Date:

08/03/2013

Priority Country:

United States (US)

3

Priority Number:

201361780444 P

Priority Date:

13/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/565; A61P 29/00; C07J 63/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/07

Publication date:

06/06/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

202102

Publication date:

13/01/2021

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20230000202A

Date Registered:

27/04/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

NOVAGRAAF BREVETS

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

REATA PHARMACEUTICALS HOLDINGS, LLC

Address:

5320 Legacy Drive, Plano, 75024, Texas, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/04/2027

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

19/03/2026

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
27/04/2023	Request For Change	5
11/05/2023	Outgoing Correspondence	1
22/03/2021	Outgoing Correspondence	1
17/03/2021	Power Of Attorney	2